Chinese Journal of Magnetic Resonance

   

Clinical Advances of Hyperpolarized 129Xe Magnetic Resonance Imaging in Lung Diseases

LI Xinyang1,2#,ZHU Zirui3#,ZHANG Ming4,5,LUO Yingying4,5,BIAN Xiangbing6,ZHOU Xin4,5,XUE Zhiqiang2*   

  1. 1. Medical School of Chinese PLA, Beijing 100853, China; 2. Department of Thoracic Surgery, The First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China; 3. Department of Thoracic Surgery, Hainan Hospital of Chinese PLA General Hospital, Sanya 572013, China; 4. State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan 430071, China; 5. University of Chinese Academy of Sciences, Beijing 100049, China; 6. Department of Radiology, The First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China
  • Received:2026-02-03 Revised:2026-05-21 Accepted:2026-06-12
  • Contact: XUE Zhiqiang E-mail:xuezhiqiang301@126.com

Abstract:

Hyperpolarized 129Xe magnetic resonance imaging (MRI) is an emerging, noninvasive, radiation-free pulmonary functional imaging technique. By inhalation of hyperpolarized 129Xe gas and the use of multiple MRI sequences, it enables visualized and quantitative assessment of pulmonary ventilation, gas exchange, and alveolar microstructural alterations. Compared with pulmonary function tests (PFT) and computed tomography (CT), its main advantage lies in its greater sensitivity for detecting small airway abnormalities, gas exchange impairment, and disease heterogeneity. The main methods for pulmonary function assessment using hyperpolarized 129Xe MRI are reviewed, and their clinical applications and preclinical advances in lung disease diagnosis and management are discussed in comparison with PFT and CT, offering a new technical perspective for pulmonary functional imaging and precise assessment.

Key words: magnetic resonance imaging, Xenon-129, lung disease, review